UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Larkspur Health Acquisition Corp.
(Exact Name of Registrant as Specified in its Charter)
Delaware | 86-2685744 | |
(State of Incorporation | (I.R.S. Employer | |
or Organization) | Identification No.) |
100 Somerset Corporate Blvd., 2nd Floor | ||
Bridgewater, New Jersey | 08807 | |
(Address of Principal Executive Offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class to be so Registered |
Name of Each Exchange on Which Each Class is to be Registered |
|
Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant | The Nasdaq Stock Market LLC | |
Class A Common Stock, par value $0.0001 per share | The Nasdaq Stock Market LLC | |
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share | The Nasdaq Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement file number to which this form relates: 333- 256056.
Securities to be registered pursuant to Section 12(g) of the Act: None.
Item 1. | Description of Registrant's Securities to be Registered. |
A description of the Units, Class A Common Stock, and Warrants to be registered hereunder is contained in the section entitled “Description
of Securities” in the Prospectus included in Larkspur Health Acquisition Corp.’s (the “Registrant”) Registration
Statement on Form S-1 (Registration No. 333-256056) initially filed with the Securities and Exchange Commission on May 13, 2021, as amended
from time to time (the “Registration Statement”). This information is incorporated herein by reference. Any form of prospectus
or prospectus supplement to the Registration Statement that includes such descriptions and that are filed subsequently to the Registration
Statement are hereby also incorporated by reference herein.
Item 2. | Exhibits. |
Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Global Market LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
1
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Date: December 20, 2021 | LARKSPUR HEALTH ACQUISITION CORP. | |
By: | /s/ Daniel J. O’Connor | |
Name: | Daniel J. O’Connor | |
Title: | Chief Executive Officer |
2